Právní předpis byl sestaven k datu 29.12.2023.
Zobrazené znění právního předpisu je účinné od 29.12.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2024
420/2023 Sb.
420
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 19. prosince 2023
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2024
&xxxx;
Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx a x xxxxx některých souvisejících xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2024:
1.&xxxx;Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x)&xxxx;xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 ne méně xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1&xxxx;25 mikrogramů
Pertussis xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1&xxxx;25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1&xxxx;8 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx X (XXx)2,3&xxxx;10 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx (XXX)
xx xxx 1 (xxxx Xxxxxxx)4&xxxx;40 D xxxxxxxx antigenu
typus 2 (xxxx XXX-1)4&xxxx;8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4&xxxx;32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 mikrogramů
conj. xxx xxxxxx. tetanico xxxx nosný xxxxxxx xxxxxxxxx 25 mikrogramů
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Al(OH)3) 0,5 xxxxxxxxx Xx3+
2&xxxx;xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx buněk (Xxxxxxxxxxxxx cerevisiae)
3 adsorbováno na xxxxxxxxxxx hlinitý (XxXX4) 0,32 xxxxxxxxx Al3+
4 pomnoženo xx XXXX xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1&xxxx;(0,5 ml) obsahuje:
Diphtheriae xxxxxxxxxx ne xxxx xxx 20 mezinárodních xxxxxxxx (IU)2
Tetani xxxxxxxxxx xx xxxx xxx 40 mezinárodních jednotek (XX)2
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 D xxxxxxxx xxxxxxxx4
xx xxx 2 (MEF-1) 8 X jednotek xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B5 10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx phosphas xxxxxxxxxx xxxxxxxxxx B 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx cum xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2&xxxx;xxxx spodní xxx xxxxxxxxxxxxx (p = 0,95)
3&xxxx;xxxxxxxxx na XXXX buňkách
4 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx metodou
5 vyrobeno xxxxxxxxxxxxx XXX xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx)&xxxx;Xxxxxxx proti xxxxxxx, xxxxxx, xxxxxxxx xxxxx (acelulární xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx) x konjugovaná xxxxxxx proti Haemophilus xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx méně xxx 20 XX
Xxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 40 IU
Antigena Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx xxxxxxxxxx (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X&xxxx;2,3&xxxx;10 mikrogramů
Virus poliomyelitidis (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 mikrogramy conjunctum xxx proteinům meningococci xxxxx x2&xxxx;50 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx hlinitý (0,17 xx Al3+)
2 adsorbováno xx hydratovaný hydroxid xxxxxxx sulfát (0,15 xx Xx3+)
3&xxxx;xxxxxxxx xxxxxxxxxxxxx XXX technologií v xxxxxxxxxxxx buňkách Xxxxxxxxxxxxx xxxxxxxxxx
4&xxxx;xxxxxxxxx xx Vero xxxxxxx
5&xxxx;xxxx xxxxxxxxxxxx množství xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 xxxxxxxxxx
*&xxxx;xxxxxxxxxxx xx xxxxxxxx xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx)&xxxx;Xxxxxxxx látka xxxxx xxxxxxx, xxxxxx x dávivému xxxxx (xxxxxxxxxx) se xxxxxxxx xxxxxxx antigenů (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 IU* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 mikrogramu
Haemagglutinum xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx fosforečnan xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
*&xxxx;Xxxx xxxxxx hranice xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
XXXX
1xx)&xxxx;Xxxxxxxx látka xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) se sníženým xxxxxxx antigenů (Tdap)
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 ne xxxx xxx 20 mezinárodních xxxxxxxx (IU) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1&xxxx;8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1&xxxx;8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1&xxxx;2,5 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+&xxxx;x xxxxxxxxxxx xxxxxxx (XXXX4) 0,2 xxxxxxxxx Al3+
1c) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
Xxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x)&xxxx;xxxxxxxx xxxxx xxxxx tetanu:
Jedna xxxxx xxxxxxxx:
Xxxxxx anatoxinum - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x)&xxxx;xxxxxxxx xxxxx xxxxx virové hepatitidě X x xxxxxx xxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 xxxxxxxxxx
1x)&xxxx;xxxxxxxx xxxxx proti virové xxxxxxxxxx B x xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis hepatitidis X - 20 xxxxxxxxxx
1x)&xxxx;xxxxxxxx látka xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1&xxxx;(XXX 4385) xxx. 103,7&xxxx;xxxxxxxx dávka pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2&xxxx;(Xxxxxx XX 27/3) xxx. 103,0&xxxx;xxxxxxxx dávka xxx buněčnou xxxxxxx503
1&xxxx;xxxxxxxxx xx xxxxxxx kuřecích xxxxxx
2&xxxx;xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění obsahuje xxxxx dávka (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx xxx 1x103&xxxx;XXXX50*
Xxxxx parotitidis1 vivum attenuatum (xxxx Jeryl Lynn™, xxxxxxx B) ne xxxx xxx 12,5x103&xxxx;XXXX50*
Xxxxx xxxxxxxx2&xxxx;xxxxx attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx než 1x103&xxxx;XXXX50*
*&xxxx;50% infekční dávka xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx xx xxxxxxx kuřecích xxxxxx.
2&xxxx;xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
1x)&xxxx;xxxxxxxx xxxxx xxxxx dětské xxxxxxxx obrně x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney) ..... 40 antigenních X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx typus 2 (XXX-1) .......... 8 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ........ 32 xxxxxxxxxxx X xxxxxxxx*
*&xxxx;xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx pomocí xxxxxx imunochemické metody.
1ch) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxxxxx xxxxxxxx:
1xxx)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1x&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx polysaecharidum xxxxxxxxx 41&xxxx;2,2 μx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1&xxxx;4,4 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F1 2,2 μx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 μg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 141&xxxx;2,2 μg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx polysaecharidum xxxxxxxxx 19A1 2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X1&xxxx;2,2 μx
1 Konjugován x xxxxxx xxxxxxxxx CRM197 x xxxxxxxxxx na xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx).
X
1xxx)&xxxx;xxxxx xxxxxxxxxxxxx xxxxxxxx
xx 25 mikrogramech xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10X, 11A, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X.
XXXX
1xxx)&xxxx;xxxxxxxxxxx očkovací látka xxxxx pneumokokovým xxxxxxxx
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypů 1&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 3&xxxx;1,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 4 1,2 2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 5&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 6X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 6X&xxxx;1,2&xxxx;4,4 μx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 8 1,2 2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 10X&xxxx;1,2&xxxx;2,2 μg
polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 11X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 12X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 14&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 15X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 18X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 19X&xxxx;1,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 19X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 22X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33X&xxxx;1,2&xxxx;2,2 μx
1 Xxxxxxxxxx x xxxxxx xxxxxxxxx CRM197 (přibližně 51 μx xx dávku)
2 Xxxxxxxxxx na fosforečnan xxxxxxx (0,125 mg xxxxxxx xx xxxxx)
1x)&xxxx;xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx obrně (inaktivovaná xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1&xxxx;- xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1-&xxxx;8 mikrogramů
Pertussis haemagglutinum xxxxxxxxxxxx1&xxxx;- 8 xxxxxxxxxx
Xxxxxxxxx1&xxxx;2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xx xxx 1 (xxxx Xxxxxxx)2&xxxx;- 40 X xxxxxxxx antigenu
typus 2 (xxxx MEF-1)2 - 8 X xxxxxxxx antigenu
typus 3 (kmen Saukett)2 - 32 X xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid hlinitý (Xx(XX)3) 0,3 xxxxxxxxx Xx3+&xxxx;x fosforečnan xxxxxxx (XxXX4) 0,2 miligramu Xx3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xxxxxxxxx 2 XX* (2,5 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 IU* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 mikrogramů
Pertactinum 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X jednotek xxxxxxxx
xx xxx 2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 mg xxxxxxx)
*&xxxx;Xxxx spodní hranice xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx testu xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
**&xxxx;Xxxxxxxxxxx na Xxxx xxxxxxx.
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 ml) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3&xxxx;- 20 xxxxxxxxxx
1 xxxxxxxxxx xx XX04X xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2&xxxx;50 xxxxxxxxxx
2 xxxxxxxxxxx xx fosforečnan xxxxxxx (celkem 0,5 xxxxxxxxx Xx3+)
3 vyrobeno xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae) xxxxxxxxxxxxx DNA xxxxxxxxxxx.
2.&xxxx;Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B ve xxxxxxx pro xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x)&xxxx;xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx A virus xxxxxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx proti xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) min. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1&xxxx;(XXX 4385) min. 103,7&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Rubeolae xxxxx xxxxxxxxxx2&xxxx;(Xxxxxx RA 27/3) xxx. 103,0&xxxx;xxxxxxxx dávka xxx buněčnou kulturu503
1 pomnoženo xx xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3&xxxx;50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
2xx)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103&xxxx;XXXX50*
Xxxxx parotitidis1 vivum attenuatum (xxxx Xxxxx Xxxx™, xxxxxxx X) ne xxxx než 12,5x103&xxxx;XXXX50*
Xxxxx xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně xxx 1x103&xxxx;XXXX50*
*&xxxx;50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2&xxxx;xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
3.&xxxx;Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxx očkování
3a) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x)&xxxx;xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x)&xxxx;xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx obsahuje:
Morbillorum virus xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx pro buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(XXX 4385) xxx. 103,7&xxxx;xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2&xxxx;(Xxxxxx XX 27/3) xxx. 103,0&xxxx;xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
1&xxxx;xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3&xxxx;50% infekční xxxxx tkáňové kultury
NEBO
3ca) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám
Po xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1&xxxx;xxxxx attenuatum (xxxx Xxxxx Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103 CCID50*
Virus rubeolae2 vivum xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx než 1x1 103&xxxx;XXXX50*
*&xxxx;50% xxxxxxxx dávka xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx xx xxxxxxx kuřecích xxxxxx.
2&xxxx;xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 fibroblastech.
Ministr:
prof. XXXx. Xxxxx, XXx, XXX, XXXX, v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 420/2023 Sb. xxxxx xxxxxxxxx xxxx 29.12.2023.
Xx xxx uzávěrky xxxxxx xxxxxxx nebyl xxxxx xx doplňován.
Znění jednotlivých xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx v xxxxxxxx xxxx aktualizováno, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.